374 related articles for article (PubMed ID: 24442210)
1. New insights into the pathogenesis of IgA nephropathy.
Floege J; Moura IC; Daha MR
Semin Immunopathol; 2014 Jul; 36(4):431-42. PubMed ID: 24442210
[TBL] [Abstract][Full Text] [Related]
2. Role of IgA receptors in the pathogenesis of IgA nephropathy.
Lechner SM; Papista C; Chemouny JM; Berthelot L; Monteiro RC
J Nephrol; 2016 Feb; 29(1):5-11. PubMed ID: 26572664
[TBL] [Abstract][Full Text] [Related]
3. Pathogenic role of IgA receptors in IgA nephropathy.
Monteiro RC
Contrib Nephrol; 2007; 157():64-9. PubMed ID: 17495439
[TBL] [Abstract][Full Text] [Related]
4. Murine Models of Human IgA Nephropathy.
Suzuki H; Suzuki Y
Semin Nephrol; 2018 Sep; 38(5):513-520. PubMed ID: 30177023
[TBL] [Abstract][Full Text] [Related]
5. Both IgA nephropathy and alcoholic cirrhosis feature abnormally glycosylated IgA1 and soluble CD89-IgA and IgG-IgA complexes: common mechanisms for distinct diseases.
Tissandié E; Morelle W; Berthelot L; Vrtovsnik F; Daugas E; Walker F; Lebrec D; Trawalé JM; Francoz C; Durand F; Moura IC; Paradis V; Moreau R; Monteiro RC
Kidney Int; 2011 Dec; 80(12):1352-63. PubMed ID: 21866091
[TBL] [Abstract][Full Text] [Related]
6. New insights in the pathogenesis of IgA nephropathy.
Monteiro RC
Nefrologia; 2005; 25 Suppl 2():82-6. PubMed ID: 16050408
[TBL] [Abstract][Full Text] [Related]
7. Fcalpha receptor (CD89) mediates the development of immunoglobulin A (IgA) nephropathy (Berger's disease). Evidence for pathogenic soluble receptor-Iga complexes in patients and CD89 transgenic mice.
Launay P; Grossetête B; Arcos-Fajardo M; Gaudin E; Torres SP; Beaudoin L; Patey-Mariaud de Serre N; Lehuen A; Monteiro RC
J Exp Med; 2000 Jun; 191(11):1999-2009. PubMed ID: 10839814
[TBL] [Abstract][Full Text] [Related]
8. Soluble CD89 is a critical factor for mesangial proliferation in childhood IgA nephropathy.
Cambier A; Gleeson PJ; Abbad L; Canesi F; da Silva J; Bex-Coudrat J; Deschênes G; Boyer O; Rabant M; Ulinski T; Hogan J; Peuchmaur M; Berthelot L; Monteiro RC
Kidney Int; 2022 Feb; 101(2):274-287. PubMed ID: 34756952
[TBL] [Abstract][Full Text] [Related]
9. Renal deposition and clearance of recombinant poly-IgA complexes in a model of IgA nephropathy.
Xie X; Liu P; Gao L; Zhang X; Lan P; Bijol V; Lv J; Zhang H; Jin J
J Pathol; 2021 Jun; 254(2):159-172. PubMed ID: 33660264
[TBL] [Abstract][Full Text] [Related]
10. Pathogenic significance of IgA receptor interactions in IgA nephropathy.
Monteiro RC; Moura IC; Launay P; Tsuge T; Haddad E; Benhamou M; Cooper MD; Arcos-Fajardo M
Trends Mol Med; 2002 Oct; 8(10):464-8. PubMed ID: 12383768
[TBL] [Abstract][Full Text] [Related]
11. [Pathogenesis of Berger's disease: recent advances on the involvement of immunoglobulin A and their receptors].
Monteiro RC; Leroy V; Launay P; Moura IC; Arcos-Fajardo M; Benhamou M; Haddad E
Med Sci (Paris); 2003 Dec; 19(12):1233-41. PubMed ID: 14691748
[TBL] [Abstract][Full Text] [Related]
12. The IgA1 immune complex-mediated activation of the MAPK/ERK kinase pathway in mesangial cells is associated with glomerular damage in IgA nephropathy.
Tamouza H; Chemouny JM; Raskova Kafkova L; Berthelot L; Flamant M; Demion M; Mesnard L; Paubelle E; Walker F; Julian BA; Tissandié E; Tiwari MK; Camara NO; Vrtovsnik F; Benhamou M; Novak J; Monteiro RC; Moura IC
Kidney Int; 2012 Dec; 82(12):1284-96. PubMed ID: 22951891
[TBL] [Abstract][Full Text] [Related]
13. Critical Role of Kupffer Cell CD89 Expression in Experimental IgA Nephropathy.
Xu L; Li B; Huang M; Xie K; Li D; Li Y; Gu H; Fang J
PLoS One; 2016; 11(7):e0159426. PubMed ID: 27437939
[TBL] [Abstract][Full Text] [Related]
14. Characteristics of patients with coexisting IgA nephropathy and membranous nephropathy.
Chen P; Shi SF; Qu Z; Zhao N; Xie XF; Lv JC; Liu LJ; Zhang H
Ren Fail; 2018 Nov; 40(1):213-218. PubMed ID: 29619862
[TBL] [Abstract][Full Text] [Related]
15. Transferrin receptor engagement by polymeric IgA1 induces receptor expression and mesangial cell proliferation: role in IgA nephropathy.
Tamouza H; Vende F; Tiwari M; Arcos-Fajardo M; Vrtovsnik F; Benhamou M; Monteiro RC; Moura IC
Contrib Nephrol; 2007; 157():144-7. PubMed ID: 17495453
[TBL] [Abstract][Full Text] [Related]
16. The glomerular response to IgA deposition in IgA nephropathy.
Moura IC; Benhamou M; Launay P; Vrtovsnik F; Blank U; Monteiro RC
Semin Nephrol; 2008 Jan; 28(1):88-95. PubMed ID: 18222350
[TBL] [Abstract][Full Text] [Related]
17. Recurrent IgA nephropathy is predicted by altered glycosylated IgA, autoantibodies and soluble CD89 complexes.
Berthelot L; Robert T; Vuiblet V; Tabary T; Braconnier A; Dramé M; Toupance O; Rieu P; Monteiro RC; Touré F
Kidney Int; 2015 Oct; 88(4):815-22. PubMed ID: 26061544
[TBL] [Abstract][Full Text] [Related]
18. A pilot and comparative study between pathological and serological levels of immunoglobulin and complement among three kinds of primary glomerulonephritis.
Dong J; Peng T; Gao J; Jia X; Yan G; Wang Y
BMC Immunol; 2018 Jun; 19(1):18. PubMed ID: 29925312
[TBL] [Abstract][Full Text] [Related]
19. Gluten exacerbates IgA nephropathy in humanized mice through gliadin-CD89 interaction.
Papista C; Lechner S; Ben Mkaddem S; LeStang MB; Abbad L; Bex-Coudrat J; Pillebout E; Chemouny JM; Jablonski M; Flamant M; Daugas E; Vrtovsnik F; Yiangou M; Berthelot L; Monteiro RC
Kidney Int; 2015 Aug; 88(2):276-85. PubMed ID: 25807036
[TBL] [Abstract][Full Text] [Related]
20. Aberrantly glycosylated IgA1 as a factor in the pathogenesis of IgA nephropathy.
Tanaka M; Seki G; Someya T; Nagata M; Fujita T
Clin Dev Immunol; 2011; 2011():470803. PubMed ID: 21318178
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
